Skip to content
People

Jeffrey Landau

Chief Executive Officer at Stipple Bio.

Earliest Form D on file: Apr 2026

Filed Apr 6, 2026

Stipple Bio

Cancer drugs aimed at tumor-specific cell surface markers

Biotech, Cambridge MA

Signed as Chief Executive Officer

$65.1M

sold of $100.2M offered

Form D

LinkedIn

Network

At Stipple Bio

6 people